Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery
BRAINS
1 other identifier
observational
150
1 country
1
Brief Summary
Despite global efforts, the prevalence of obesity continues to rise, with rates in Canada tripling over the past three decades. In addition to the well-established risk of cardiometabolic conditions such as heart disease and diabetes, obesity has been associated with cognitive decline and an increased risk of dementia later in life. Sleeve gastrectomy, the most widely used surgical treatment for severe obesity, has proven effective in promoting significant weight loss and improving overall health. Emerging research, including our recent brain imaging study, suggests that this surgery may also have a positive impact on brain health. Our findings demonstrated significant improvements, with patients experiencing reductions in brain age by 2.9 and 5.6 years 12 and 24 months post-surgery, respectively. Despite these promising results, the long-term effects of sleeve gastrectomy on brain health and cognitive function remains poorly understood. While some patients experience cognitive improvements following surgery, others do not, and the factors driving this variability remain unknown. This proposal aims to comprehensively investigate the impact of bariatric surgery on brain health by examining its cognitive consequences, determinants, and drivers. Understanding the key factors that contribute to brain health improvements after bariatric surgery is essential for optimizing its benefits, preventing relapse and developing personalized interventions to maintain or enhance brain health in individuals living with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
Study Completion
Last participant's last visit for all outcomes
March 31, 2031
July 16, 2026
July 1, 2026
4.3 years
July 9, 2026
July 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Estimated Brain Age
Difference between MRI-predicted brain age and chronological age based (delta age, years) derived from a validated machine learning model based on MRI modalities.
Baseline to 36 months
Secondary Outcomes (36)
Change in Executive Function Composite Score
Baseline to 36 months
Change in Processing Speed Composite Score
Baseline to 36 months
Change in Memory Composite Score
Baseline to 36 months
Change in Global Cognition
Baseline to 36 months
Change in White Matter Fractional Anisotropy (FA)
Baseline to 36 months
- +31 more secondary outcomes
Interventions
Vertical sleeve gastrectomy
Eligibility Criteria
Participants with severe obesity scheduled to undergo SG at the Institut universitaire de cardiologie et pneumologie de Québec - Université Laval (IUCPQ-ULaval).
You may qualify if:
- Women or men between 18 and 65 years who meet the Guidelines for bariatric surgery (BM I≥ 30 kg/m2 with major comorbidities or BMI ≥ 35 kg/m2
You may not qualify if:
- Pregnancy
- Liver cirrhosis
- Unstable medical, surgical or psychiatric conditions
- Substance or alcohol abuse
- Medications affecting the central nervous system
- Previous gastric, oesophageal, brain, or bariatric surgeries
- Gastrointestinal inflammatory diseases or ulcers
- MRI contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Canadian Institutes of Health Research (CIHR)collaborator
Study Sites (1)
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec, G1V 4G5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andréanne Michaud, DtP, PhD
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2026
First Posted
July 15, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
March 31, 2031
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share